Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

ONTOLOGY REPORT - ANNOTATIONS


Term:bone density conservation agent
go back to main search page
Accession:CHEBI:50646 term browser browse the term
Definition:An agent that inhibits bone resorption and/or favor bone mineralization and bone regeneration. Used to heal bone fractures and to treat bone diseases such as osteopenia and osteoporosis.
Synonyms:related_synonym: anti-osteopenia agent;   anti-osteopenia agents;   anti-osteopenia drug;   anti-osteopenia drugs;   anti-osteoporosis agent;   anti-osteoporosis agents;   anti-osteoporosis drug;   anti-osteoporosis drugs;   anti-osteoporotic;   anti-osteoporotic agent;   anti-osteoporotic agents;   anti-osteoporotic drug;   anti-osteoporotic drugs;   anti-osteoporotics;   antiosteoporotic;   antiosteoporotics;   bone density conservation agents;   bone density conservation drug;   bone density conservation drugs
 alt_id: CHEBI:72497
 xref: Wikipedia:Osteoporosis


show annotations for term's descendants       view all columns           Sort by:
 





Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 19679
    role 19623
      application 19246
        pharmaceutical 19108
          drug 19108
            bone density conservation agent 5914
              (20S)-ginsenoside Rh2 10
              (2E,6R)-8-hydroxy-2,6-dimethyl-2-octenoic acid 0
              1alpha,25-dihydroxyvitamin D2 0
              25-hydroxyvitamin D2 0
              LY 117018 6
              N-oleoyl-L-serine 0
              alendronate sodium trihydrate 0
              alendronic acid 79
              alfacalcidol 24
              calcidiol + 92
              calcitonin 2
              calcitriol + 2398
              clodronic acid 238
              clodronic acid disodium salt + 0
              dihydrotachysterol 0
              disodium clodronate tetrahydrate 0
              doxercalciferol 0
              estrone + 124
              etidronate disodium 0
              etidronic acid 3
              galgravin 0
              icariin 64
              ipriflavone 5
              isoformononetin 0
              isovaleryl-L-carnitine 0
              kaempferol 3,7-di-O-alpha-L-rhamnoside 0
              medronic acid 0
              menatetrenone + 5
              raloxifene 845
              raloxifene hydrochloride 0
              sciadopitysin 2
              tamoxifen + 3166
              tauroursodeoxycholic acid 184
              tibolone 11
              toremifene 10
              vitamin D2 + 81
              xanthogalenol 0
              zoledronic acid 1484
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.